Importantly, the transfection of melanoma cells with antisense PAX3 oligonucleotides triggers cell death by inducing apoptosis [9], [10], highlighting the potential therapeutic option of targeting PAX3 in melanoma patients. This evidence concerns the gene PAX3 and melanoma.